Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction
Nucleic Acids Research · 05.07.2024 · 52 (W1) · W469-W475
DOI: 10.1093/nar/gkae254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.04.2024. Verfasst von Yoochan Myung und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The Australian Centre for Ecogenomics, The University of Queensland, Brisbane, Queensland 4072, Austra…. Hauptthemen laut MEDLINE: Deep Learning. Die Arbeit wurde bisher 371-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Victorian Government.
Abstract (Originalsprache)
Evaluating pharmacokinetic properties of small molecules is considered a key feature in most drug development and high-throughput screening processes. Generally, pharmacokinetics, which represent the fate of drugs in the human body, are described from four perspectives: absorption, distribution, metabolism and excretion—all of which are closely related to a fifth perspective, toxicity (ADMET). Since obtaining ADMET data from in vitro, in vivo or pre-clinical stages is time consuming and expensive, many efforts have been made to predict ADMET properties via computational approaches. However, the majority of available methods are limited in their ability to provide pharmacokinetics and toxicity for diverse targets, ensure good overall accuracy, and offer ease of use, interpretability and extensibility for further optimizations. Here, we introduce Deep-PK, a deep learning-based pharmacokinetic and toxicity prediction, analysis and optimization platform. We applied graph neural networks and graph-based signatures as a graph-level feature to yield the best predictive performance across 73 endpoints, including 64 ADMET and 9 general properties. With these powerful models, Deep-PK supports molecular optimization and interpretation, aiding users in optimizing and understanding pharmacokinetics and toxicity for given input molecules. The Deep-PK is freely available at https://biosig.lab.uq.edu.au/deeppk/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Biosciences, The Australian Centre for Ecogenomics, The University of Queensland, Brisbane, Queensland 4072, Australia.
- Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
- Baker Department of Cardiometabolic Health, The University of Melbourne, Parkville, Victoria 3010, Australia.
ORCID-Profile: David B Ascher
Förderung
- National Health and Medical Research Council
- Victorian Government
Zitieren
APA
Myung, Y., de Sá, A. G. C., & Ascher, D. B. (2024). Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Research, 52(W1), W469-W475. https://doi.org/10.1093/nar/gkae254
Vancouver
Myung Y, de Sá AGC, Ascher DB. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Research. 2024;52(W1):W469-W475. doi:10.1093/nar/gkae254
BibTeX
@article{Myung2024,
author = {Myung, Yoochan and de Sá, Alex G C and Ascher, David B},
title = {Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {W1},
pages = {W469--W475},
doi = {10.1093/nar/gkae254}
}
EUVIMED